Impact of Insulin Therapy on Indices of Insulin Resistance and Risk for Cardiovascular Death in Patients with Type 2 Diabetes Mellitus
The study analyzed the effect of insulin therapy in combination with oral antihyperglycemic drugs (OADs) on glycemic control and risk for coronary heart disease (CHD), as well as the 10-year risk of death from cardiovascular disease in patients with diabetes mellitus (DM) type 2. The study included 66 patients with diabetes mellitus type 2 (39 women and 27 men) aged 39–72 years with duration of diabetes 9.1 ± 1.2 years. CHD risk was calculated in terms of the atherogenic index, and SCORE index. Treatment with long-acting insulin in combination with OADs led to a significant improvement in carbohydrate metabolism, the positive dynamics of lipid metabolism, reduce of microalbuminuria, insulin resistance, and significantly reduced the risk of CHD and a 10-year risk of fatal cardiovascular disease.
Full Text:PDF (Українська)
Cranberry M.C., Fonseca V.A. Cardiovascular risk factors associated with insulin resistance: effects of oral antidiabetic agents // Am. J. Cardiovasc. Drugs. — 2005. — Vol. 5. — P. 201-209.
Kaiser A., Vollenweider P., Waeber G., Marques-Vidal P. Prevalence, awareness and treatment of type 2 diabetes mellitus in Switzerland: the CoLaus study // Diabet. Med. — 2012. — Vol. 29, № 2. — P. 190-197.
Lakka H.M., Laaksonen D.E. et al. The metabolic syndrome and total cardiovascular disease mortality in middle-age men // JAMA. — 2002. — Vol. 288, № 21. — P. 2709-2716.
Tuomilehto J., Lindstrom J., Ericsson J. et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance // N. Engl. J. Med. — 2001. — Vol. 344. — P. 1343-1350.
UK Prospective Diabetes Study Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS) // Lancet. — 1998. — Vol. 352. — P. 854-865.
- There are currently no refbacks.
Copyright (c) 2017 EMERGENCY MEDICINE
This work is licensed under a Creative Commons Attribution 4.0 International License.
© Publishing House Zaslavsky, 1997-2018